ÂÜÀòÂÒÂ×

Chi-Ming Li has an extensive background in genomics and molecular biology, with experience at Amgen since 2007. They have held various roles such as Senior Principal Scientist, Principal Scientist, Senior Scientist, and Scientist, where they have managed research projects in target discovery, biomarker exploration, and genetic analyses. Prior to Amgen, they worked at Columbia University as an Associate Research Scientist, specializing in oncogenesis and WNT signaling pathways. Chi-Ming holds a PhD in Biological Science from Icahn School of Medicine at Mount Sinai, a Bachelor of Science from National Taiwan University, and a Master's in Genetics from National Yang Ming University.